highperformr logo

Cartesian's Overview

Total employees329
HeadquartersGaithersburg
Founded1990

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is a clinical-stage biotechnology company pioneering messenger RNA (mRNA) cell therapies for the treatment of autoimmune diseases. The company's portfolio is led by Descartes-08, an autologous anti-BCMA mRNA CAR-T, being developed for Myasthenia Gravis and other autoimmune indications. Cartesian aims to broaden the reach of cell therapy to autoimmune diseases by engineering therapies that are purposefully designed to be administered out-patient without lymphodepleting chemotherapy.

Where is Cartesian's Headquarters?

HQ Function

The Gaithersburg headquarters serves as the primary center for Cartesian's executive leadership, research and development operations, clinical development, and corporate administrative functions.

Notable Features:

The facility is situated in a modern biotechnology park, likely equipped with advanced laboratory spaces for cell therapy research, process development, and analytics. It also includes manufacturing capabilities.

Work Culture:

Cartesian fosters a science-driven, innovative, and collaborative work environment. The culture emphasizes scientific excellence, patient focus, and a commitment to developing transformative therapies for autoimmune diseases.

HQ Significance:

Its location in the Maryland biotech corridor provides strategic access to a rich talent pool, leading research institutions, and proximity to regulatory agencies such as the U.S. Food and Drug Administration (FDA).

Values Reflected in HQ: The headquarters reflects Cartesian's commitment to cutting-edge science, innovation in cell therapy, and a focused approach to addressing unmet needs in autoimmune diseases.

Location:

Cartesian Therapeutics's operations, including research, development, and clinical trials, are primarily centered in the United States. While its therapeutic candidates, if approved, could address global patient populations, the company's current physical and operational footprint is U.S.-based. Future global expansion may occur through partnerships for clinical trials or commercialization.

Street Address:

22275 Global Drive

City:

Gaithersburg

State/Province:

Maryland

Country:

USA

Cartesian's Global Presence

Frederick, Maryland/USA

Address: Previously leased manufacturing facility in Frederick, MD

It formerly supported the company's development pipeline by providing dedicated space for specialized cell therapy manufacturing. Cartesian Therapeutics has been evaluating its future manufacturing strategy, which may include extending the lease, securing new facilities, or using contract manufacturers.

Buying Intent Signals for Cartesian

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cartesian

As of April 2025, Cartesian' leadership includes:

Murat Kalayoglu, M.D., Ph.D. - President & Chief Executive Officer
Milos Miljkovic, M.D. - Chief Medical Officer
Metin Kurtoglu, M.D., Ph.D. - Chief Operating Officer
Chris Jewell, Ph.D. - Chief Scientific Officer
Lloyd Mitchell - Chief Financial Officer

Investors of Cartesian

Cartesian has been backed by several prominent investors over the years, including:

NEA (New Enterprise Associates)
Artis Ventures
Illumina Ventures
Leading public institutional investors (post-merger and public listing)

Executive New Hires/Exits in the Last 12 Months

Hire5
Exits3

The past 12 months featured significant executive changes primarily due to the merger of Selecta Biosciences and Cartesian Therapeutics in November 2023. This led to the formation of a new leadership team for the combined entity, Cartesian Therapeutics, including a new CEO, CFO, COO, CMO, and CSO, and departures from the former Selecta Biosciences leadership.

Departures

Carsten Brunn, Ph.D., Resigned as President & CEO of Selecta Biosciences upon merger completion with Cartesian Therapeutics.
Kevin Tan, Departed from role as CFO of Selecta Biosciences.
Takashi Kishimoto, Ph.D., Transitioned from executive CSO role at Selecta Biosciences to an advisory position post-merger.

New Appointments:

Murat Kalayoglu, M.D., Ph.D., Appointed President & CEO of the newly merged Cartesian Therapeutics.
Lloyd Mitchell, Appointed Chief Financial Officer of Cartesian Therapeutics.
Metin Kurtoglu, M.D., Ph.D., Appointed Chief Operating Officer of Cartesian Therapeutics.
Milos Miljkovic, M.D., Appointed Chief Medical Officer of Cartesian Therapeutics.
Chris Jewell, Ph.D., Appointed Chief Scientific Officer of Cartesian Therapeutics.

Technology (Tech Stack) used by Cartesian

Discover the tools Cartesian uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cartesian Email Formats and Examples

Cartesian Therapeutics likely utilizes a standard corporate email format, typically combining an employee's first initial and last name, or full name, with the company domain. This is a common practice for professional communication.

[first_initial][last_name]@cartesiantherapeutics.com

Format

mkalayoglu@cartesiantherapeutics.com

Example

80%

Success rate

News and media

GlobeNewswireMarch 28, 2024

Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

Cartesian Therapeutics announced its financial results for the fiscal year ended December 31, 2023, and provided corporate updates, including progress on its lead clinical program, Descartes-08 for Myasthenia Gravis....more

GlobeNewswireJanuary 4, 2024

Cartesian Therapeutics Announces Positive Initial Data from Phase 2b Study of Descartes-08 in Myasthenia Gravis

The company reported positive initial data from its Phase 2b study of Descartes-08 in patients with generalized Myasthenia Gravis, indicating potential for clinically meaningful improvement and a favorable safety profile....more

GlobeNewswireNovember 14, 2023

Selecta Biosciences and Cartesian Therapeutics Announce Closing of Merger

Selecta Biosciences and Cartesian Therapeutics announced the successful completion of their merger. The combined company now operates as Cartesian Therapeutics, Inc., trading on Nasdaq under 'RNAC', and is focused on advancing Cartesian's portfolio of RNA cell therapies....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cartesian, are just a search away.